Astrazeneca Pharma India Ltd.

View in App
5164.65 -59.50 ▼-1.1%

19 April 2024, 10:10:56 AM
Volume: 1,211

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.astrazenecaindia.com/india
Market Cap 13,011.75 Cr.
Enterprise Value(EV) 12,491.50 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 55.72 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 93.41 Trailing Twelve Months Ending 2023-12
Industry PE 41.01 Trailing Twelve Months Ending 2023-12
Book Value / Share 268.31 Trailing Twelve Months Ending 2023-12
Price to Book Value 19.40 Calculated using Price: 5,204.70
Dividend Yield 0.31 Period Ending 2023-03
No. of Shares Subscribed 2.50 Cr. 25,000,000 Shares
FaceValue 2
About Astrazeneca Pharma India Ltd.
The Company is engaged in the business of manufacture, distribution and marketing of life-changing medicines in crucial areas of healthcare including oncology, cardiovascular, diabetes, renal, metabolic and respiratory. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology and respiratory. AstraZeneca Pharma India is a subsidiary of AstraZeneca Pharmaceuticals AB, Sweden, which is an indirect subsidiary of AstraZeneca PLC.

Astrazeneca Pharma India Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Astrazeneca Pharma India Ltd. Performance

View details >>
1 Day
-1.14%
1 Week
-4.33%
1 Month
+1.32%
3 Month
-18.21%
6 Month
+8.88%
1 Year
+61.59%
2 Year
+87.09%
5 Year
+127.95%
10 Year
+390.82%

Astrazeneca Pharma India Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -12.93 3.43 10.63 11.12 20.03 21.83 22.83 12.78 18.13
Return on Capital Employed (%) -12.93 3.76 18.74 18.65 26.53 34.61 31.24 17.36 24.49
Return on Assets (%) -5.04 1.25 4.25 4.76 9.34 10.57 11.31 6.65 9.37

Astrazeneca Pharma India Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 151 156 223 247 301 364 456 511 589 655
Non Curr. Liab. 1 39 89 110 23 44 45 74 69 -10
Curr. Liab. 260 234 202 219 268 367 373 392 484 435
Minority Int.
Equity & Liab. 412 429 514 575 591 776 874 977 1,142 1,081
Non Curr. Assets 148 162 250 243 178 193 186 212 206 127
Curr. Assets 263 267 263 333 413 582 689 765 936 954
Misc. Exp. not W/O
Total Assets 412 429 514 575 591 776 874 977 1,142 1,081

Astrazeneca Pharma India Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 517 564 544 571 728 832 814 806 1,003 1,197
Other Income 8 7 14 12 16 13 13 15 26 34
Total Income 525 571 558 583 745 845 826 820 1,029 1,231
Total Expenditure -531 -547 -507 -525 -657 -711 -678 -719 -838 -1,002
PBIDT -6 23 51 59 88 134 148 101 191 229
Interest -1 -1 -1 -1 -1
Depreciation -15 -17 -16 -15 -15 -19 -20 -17 -16 -15
Taxation -1 -15 -18 -18 -42 -34 -21 -35 -49
Exceptional Items -40 -24
PAT -21 5 20 26 54 72 93 62 99 139
Adjusted EPS -8 2 8 10 22 29 37 25 40 56

Astrazeneca Pharma India Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -1 -46 57 38 9 55 87 105 101 58
Cash Fr. Inv. -15 -19 -4 0 -9 4 -171 173 5 18
Cash Fr. Finan. 86 -1 -6 -9 -9 -24
Net Change 71 -64 53 38 -1 59 -90 269 96 52
Cash & Cash Eqvt 88 23 76 115 114 173 84 352 448 500

Astrazeneca Pharma India Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00 75.00
Public 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00 25.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Astrazeneca Pharma India Ltd. Announcements

View details >>
Fri, 12 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018
AstraZeneca Pharma India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Mon, 08 Apr 2024
Disclosure under SEBI Takeover Regulations
AstraZeneca pharmaceuticals ABￂﾠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaￂﾠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ￂﾠ
Mon, 08 Apr 2024
Shareholders meeting
AstraZeneca Pharma India Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has informed the Exchange regarding voting results along with copy of scrutinizers report.

Astrazeneca Pharma India Ltd. Technical Scans

View details >>
Thu, 18 Apr 2024
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years

Astrazeneca Pharma India Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,015.10 1,511.55 -0.3%
Cipla Ltd. 108,808.58 1,340.70 -0.5%
Dr. Reddy's Laboratories Ltd. 99,408.67 5,922.10 -0.6%
Divi's Laboratories Ltd. 98,683.96 3,670.85 -1.0%
Mankind Pharma Ltd. 96,037.07 2,375.85 -0.8%
Zydus Lifesciences Ltd. 94,213.69 930.90 -0.6%
Apollo Hospitals Enterprise Ltd. 87,250.69 6,134.00 +1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.87 1,511.55 -0.3%
Cipla Ltd. Consolidated 2023-12 29.34 1,340.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.01 5,922.10 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 71.36 3,670.85 -1.0%
Mankind Pharma Ltd. Consolidated 2023-12 55.61 2,375.85 -0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.68 930.90 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 110.54 6,134.00 +1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.83 1,511.55 -0.3%
Cipla Ltd. Consolidated 2023-12 4.20 1,340.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,922.10 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.57 3,670.85 -1.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.81 2,375.85 -0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.00 930.90 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 12.92 6,134.00 +1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,511.55 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,340.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,922.10 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,670.85 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,375.85 -0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 930.90 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,134.00 +1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,511.55 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,340.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,922.10 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,670.85 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,375.85 -0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 930.90 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,134.00 +1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,511.55 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,340.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,922.10 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,670.85 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,375.85 -0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 930.90 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,134.00 +1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,511.55 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,340.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,922.10 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,670.85 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,375.85 -0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 930.90 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,134.00 +1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,511.55 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,340.70 -0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,922.10 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,670.85 -1.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,375.85 -0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 930.90 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,134.00 +1.0%

Astrazeneca Pharma India Ltd. FAQ's

What is Astrazeneca Pharma I share price?
Can I buy Astrazeneca Pharma I shares now?
What is the Dividend Yield of Astrazeneca Pharma I?
What is the Market Cap of Astrazeneca Pharma I?
What are the key metrics to analyse Astrazeneca Pharma I?
What is the 52 Week High and Low of Astrazeneca Pharma I?
What is the trend of Astrazeneca Pharma I share price?